Editorial Policies

Aims and Scope

"Farmateka" is peer-reviewed scientific and practical medical journal, intended for physicians, pediatricians, cardiologists, endocrinologists, gastroenterologists, pulmonologists, dermatologists, obstetricians, gynecologists, urologists, oncologists, neurologists, rheumatologists, and other doctors.

The "Farmateka" journal has been published since 1994. Starting with the first issues of the journal, information for practitioners about modern drugs, their therapeutic action, pharmacokinetics and pharmacodynamics, side effects are provided on its pages; the recent advances in medical science and technology, significant clinical studies of drugs, the results of international and Russian congresses and conferences are reported. Each issue contains news on the most relevant medical events and discoveries.

Goals and objectives of the journal:

  • Regular and timely coverage of information on the latest achievements and prospects for the development of domestic and foreign medical science and health care.
  • Publication of high-quality scientific materials that meet international standards.
  • Systematic publication of materials that contribute to the improvement of scientific knowledge and qualifications of medical practitioners in the framework of continuous medical education.
  • Enhancement of opportunities for the distribution and indexing of scientific works in various domestic and foreign citation bases.

All issues of the journal are thematic and are dedicated to specific areas of clinical medicine. Since 2018, the journal comes out with the periodicity of 14 issues per year. The average volume of full-color issue is 96–144 pages. The circulation of the journal exceeds 25 thousand copies. Circulation certified by the National Circulation Service. The “Farmateka” journal is sent by subscription and distributed on medical congresses, conventions and conferences, and on training cycles for doctors and students in the territory of the Russian Federation.

The journal is published on the following main subjects: Pediatrics, Gastroenterology/Hepatology, Obstetrics and Gynecology, Uronephrology, Pulmonology/ENT Diseases, Endocrinology, Neurology/Rheumatology, Oncology, Cardiology/Neurology, Therapy, Dermatology/Cosmetology, Allergology.

The “Farmateka” journal publishes original articles, clinical reviews, reviews and lectures on the most topical issues of pharmacotherapy, prepared by leading experts in relevant fields of medicine.

The “Farmateka” journal is intended to provide for readers - a wide range of doctors and medical scientists - with the most up-to-date information on the results of clinical studies and new, innovative diagnostic and treatment methods.

Every year, collection of selected scientific articles on endocrinology "Modern aspects of pharmacotherapy of endocrine diseases" edited by M. B. Antsiferov (Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Natural Sciences, Deputy Director of the Institute of Diabetes, Head of the Diabetic Foot Unit of the ERC; Chief Endocrinologist of the Moscow Healthcare Department, Chief Physician of the Endocrinology Dispensary of the Moscow Healthcare Department, Moscow, Russia) is published as part of the “Farmateka” journal. The collection is arranged to coincide with the Moscow City Congress of Endocrinologists.

Farmateka journal is included in the in the list of publications recommended by the Higher Attestation Commission (HAC) for the following medical sciences:
14.01.01 - Obstetrics and Gynecology (Medical Sciences);
14.01.02 - Endocrinology (Medical Sciences);
14.01.05 - Cardiology (Medical Sciences);
14.01.11 - Nervous Diseases (Medical Sciences);
14.01.25 - Pulmonology (Medical Sciences);
14.01.03 - Diseases of the Ear, Nose and Throat (Medical Sciences);
14.01.04 - Internal Diseases (Medical Sciences);
14.01.08 - Pediatrics (Medical Sciences);
14.01.10 - Skin and Sexually Transmitted Diseases (Medical Sciences);
14.01.12 - Oncology (Medical Sciences);
14.01.22 - Rheumatology (Medical Sciences);
14.01.28 - Gastroenterology (Medical Sciences).

 
 

Peer Review Process

Scientific Manuscripts submitted to “Farmateka” journal editors office for publishing on paper and electronic media are to be reviewed.

In 10 days Managing Editor reviews the submitted article for the conformance to the requirements of the journal and after passes it to science editor who determines compliance with scope of the journal, scientific value and sends the article to reviewer.

The reviewer can be a member of editorial board or an invited professional specializing in the theme of the article.

Reviewing period is 1 week, is controlled by the editor’s office and can be changed.

The review has to point out the correlation of the title with the content, actuality and academicism, accomplishments and limitations, publishing viability is examined. On the basis of the review the following options are available: a. the provided article is recommended for publishing; b. limitations identified by reviewer are to be corrected; c. another professional review is demanded; d. publication is unadvisable (a motivated denial is provided). The review is closed-door.

The review is sent by provided email to the author of the article upon request; also upon request to Ministry of Education and Science (MinObrNauki) and to State Commission for Academic Degrees and Titles of MinObrNauki.

In case if the reviewer suggests correcting or improving the article, the review is provided with the suggestion to take into account the remarks while working on new variant of the article or to dispose them with reason (partially or completely). If needed an improved article is sent for review again.

A motivated denial is provided to the author if the article is not published. An additional review can be performed by another specialist upon request of the author.

The final decision is made by editorial board via opened direct voting. In some cases publishing is available upon the decision of the Chief Editor. Editorial board decision is stated in protocol of editorial board meeting.

Original reviews are stored for 5 years.

ReviewerResponsibilities

  • To contribute to the decision-making process about the appropriateness of publishing the article and to assist in improving the quality of the article, the reviewer must act objectively and in a timely manner.
  • Peer reviewer should respect the confidentiality of any information provided by the author or the editor. Peer reviewer should not retain a copy of the manuscript.
  • Reviewer should notify the editor of the material published earlier in this or any other publication, if any.
  • Reviewer should inform the editor and, if necessary, pass the article to alternative reviewer, in the case of a potential conflict of interest (financial, organizational or other relationship between the reviewer and the author).
  • Reviewer should follow the position statements developed at the 2nd World Conference on Research Integrity, Singapore (https://wcrif.org/documents/327-singapore-statement-a4size/file)

Article Retraction

Retraction of already published article is an extreme measure and is used in the event of establishing the facts that were not known during the review process such as:

  • violations of law or defamation
  • fraudulent or inaccurate use of data, especially those that might pose a serious health risk.

Retraction Guidelines

  1. The retraction may be initiated by their author(s), reader(s), reviewer(s), the Journal editor(s) and publishers, by written request to the Journal in which the article was published.
  2. The conflict resolution committee of the corresponding journal examines the received request
  3. The decision on article retraction is made by conflict resolution committee of the corresponding journal if there is sufficient evidence in favor of retraction
  4. The committee should notify the initiator of the article retraction on the results of consideration of the request in writing
  5. If the committee decides to retract the article, in the corresponding journal publishes information on that article retraction, indicating article metadata
  6. If article is retracted from the Journal, indexed with any database, a letter should be sent to the database stating that the article was retracted and indicating the reasons for retraction.

Plagiarism

While considering article, the Editorial Board may screen the submitted manuscript for copied material with the use of Антиплагиат http://www.antiplagiat.ru/  (plagiarism detection software). If plagiarism is identified, the COPE guidelines on plagiarism will be followed.

 

Publication Frequency

Since 2018, the journal comes out with the periodicity of 14 issues per year. The average volume of full-color issue is 96–144 pages.

The “Farmateka” journal is sent by subscription and distributed on medical congresses, conventions and conferences, and on training cycles for doctors and students in the territory of the Russian Federation.

 

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 184.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 52.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

 

Indexing

Articles in journal are indexed by several systems:

 

Ethical Standards

“Bionika” publishes a number of medias, including medical and pharmaceutical  journals. Most of these journals are on behalf of scientific societies and other similar organizations.   As part of this objective, the Press itself adopts a neutral position on issues treated within its Journals. Those Journals serve to further academic discussions of topics, irrespective of their nature – whether religious, gender-based, environmental, ethical, political or other potentially or topically contentious subjects.

Publication of an article in an academic peer-reviewed journal serves several functions, one of which is to validate and preserve the “minutes” of research. It is therefore of immense importance that these “minutes” are accurate and trustworthy. The act of publishing involves many parties, each of which plays an important role in achieving these aims. It therefore follows that the author, the journal editor, the peer-reviewer, the publisher and the owner of Society-owned journals have responsibilities to meet expected ethical standards at all stages in their involvement from submission to publication of an article.

“Bionika” is committed to meeting and upholding standards of ethical behaviour at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICJME), World Association of Medical Editors (WAME), and The European Association of Science Editors (EASE), that set standards and provide guidelines for best practices in order to meet these requirements.

Editor and publisher adhere to Editorial Policy Statements, developed by The Council of Science Editors (CSE), that cover the responsibilities and rights of editors of peer-reviewed journals.

Below is a summary of our key expectations of editors, peer-reviewers and authors.

1. ETHICAL EXPECTATIONS

Editors’ responsibilities

  • To act in a balanced, objective and fair way while carrying out their expected duties, without discrimination on grounds of gender, sexual orientation, religious or political beliefs, ethnic or geographical origin of the authors.
  • To handle submissions for sponsored supplements or special issues in the same way as other submissions, so that articles are considered and accepted solely on their academic merit and without commercial influence.
  • To adopt and follow reasonable procedures in the event of complaints of an ethical or conflict nature, in accordance with the policies and procedures of the Society where appropriate. To give authors a reasonable opportunity to respond to any complaints. All complaints should be investigated no matter when the original publication was approved. Documentation associated with any such complaints should be retained.

Reviewers’ responsibilities

  • To contribute to the decision-making process, and to assist in improving the quality of the published paper by reviewing the manuscript objectively, in a timely manner
  • To maintain the confidentiality of any information supplied by the editor or author. To not retain or copy the manuscript.
  • To alert the editor to any published or submitted content that is substantially similar to that under review.
  • To be aware of any potential conflicts of interest (financial, institutional, collaborative or other relationships between the reviewer and author) and to alert the editor to these, if necessary withdrawing their services for that manuscript.
  • To follow in his work to «Singapore Statement on Research Integrity»

Authors’ responsibilities

  • To maintain accurate records of data associated with their submitted manuscript, and to supply or provide access to these data, on reasonable request. Where appropriate and where allowed by employer, funding body and others who might have an interest, to deposit data in a suitable repository or storage location, for sharing and further use by others.
  • To confirm/assert that the manuscript as submitted is not under consideration or accepted for publication elsewhere. Where portions of the content overlap with published or submitted content, to acknowledge and cite those sources. Additionally, to provide the editor with a copy of any submitted manuscript that might contain overlapping or closely related content.
  • To confirm that all the work in the submitted manuscript is original and to acknowledge and cite content reproduced from other sources. To obtain permission to reproduce any content from other sources.
  • To be ensure that any studies involving human or animal subjects conform to national, local and institutional laws and requirements (e.g. WMA Declaration of Helsinki, NIH Policy on Use of laboratory Animals, EU Directive on Use of Animals) and confirm that approval has been sought and obtained where appropriate. Authors should obtain express permission from human subjects and respect their privacy.
  • To declare any potential conflicts of interest (e.g. where the author has a competing interest (real or apparent) that could be considered or viewed as exerting an undue influence on his or her duties at any stage during the publication process).
  • To notify promptly the journal editor or publisher if a significant error in their publication is identified. To cooperate with the editor and publisher to publish an erratum, addendum, corrigendum notice, or to retract the paper, where this is deemed necessary.
  • To take full responsibility for any plagiarism of text, image or other type of graphics. Any related misconduct will be dealt in accordance with COPE algorithm.

Publisher or Society responsibilities

“Bionika” publisher and Farmateca guarantee that all published materials compliant with standards above.

2. PROCEDURES FOR DEALING WITH UNETHICAL BEHAVIOUR

Identification of unethical behaviour

  • Misconduct and unethical behaviour may be identified and brought to the attention of the editor and publisher at any time, by anyone.
  • Whoever informs the editor or publisher of such conduct should provide sufficient information and evidence in order for an investigation to be initiated. All allegations should be taken seriously and treated in the same way, until a successful decision or conclusion is reached.

Investigation

  • An initial decision should be taken by the editor, who should consult with or seek advice from the publisher, if appropriate.
  • Evidence should be gathered, while avoiding spreading any allegations beyond those who need to know.

Minor breaches

Minor misconduct might be dealt with without the need to consult more widely. In any event, the author should be given the opportunity to respond to any allegations.

Serious breaches

Serious misconduct might require that the employers of the accused be notified. The editor, in consultation with the publisher or Society as appropriate, should make the decision whether or not to involve the employers, either by examining the available evidence themselves or by further consultation with a limited number of experts.

Outcomes (in increasing order of severity; may be applied separately or in conjunction)

  • Informing or educating the author or reviewer where there appears to be a misunderstanding or misapplication of acceptable standards.
  • A more strongly worded letter to the author or reviewer covering the misconduct and as a warning to future behaviour.
  • Publication of a formal notice detailing the misconduct.
  • Publication of an editorial detailing the misconduct.
  • A formal letter to the head of the author’s or reviewer’s department or funding agency.
  • Formal retraction or withdrawal of a publication from the journal, in conjunction with informing the head of the author or reviewer’s department, Abstracting & Indexing services and the readership of the publication.
  • Imposition of a formal embargo on contributions from an individual for a defined period.
  • Reporting the case and outcome to a professional organisation or higher authority for further investigation and action.

3. BUSINESS MODEL. FEE FOR PUBLICATIONS

The publisher of the Journal – Bionika Media Publishing House – incurs all the expenses for production and publishing of the Journal, which includes organizing expert review, internet hosting and archiving. The authors are not charged for publication. PUBLICATION OF ARTICLES in the Journal is FREE! Reviewing is not paid.

4. CONFLICTS OF INTEREST POLICY

Potential conflicts of interest arise when there are financial, personal or professional conditions, which can influence the scientific judgments of a reviewer or editor and, as a consequence, on the decision of the Editorial Board concerning the publication of the article.

The Journal presumes that by submitting a paper the author states that:

  • all forms of financial support are acknowledged in the submitted article;
  • there are no commercial, financial, personal, professional involvements that might present an appearance of a conflict of interest related to the submitted article.

Otherwise, the author should make an explicit declaration of possible conflicting interests in a cover letter that accompanies the manuscript.

If there is a conflict of interests, authors may also suggest excluding any specific editors or reviewers from the peer review of their article.

Editors and reviewers should declare whether they have any conflicts of interests that may influence the judgment of the editorial board.

If there is a conflict of interest an editor or reviewer from the author of the article, the article should be transferred to another editor or reviewer, respectively.

If the editor or reviewer has conflicts of interest with any of the authors, the article should be transmitted to another editor or reviewer correspondingly.

Articles should be evaluated fairly and will not necessarily be rejected when any conflicting interests are declared by any participant of the consideration and reviewing process, because the most important criterion of manuscript evaluation is its scientific quality.

5.  PRIVACY STATEMENT

Information about the authors (surname, name, patronymic, affiliation, e-mail, contact number), which is provided by them for publication in the Journal, is becoming available for indefinite range of persons, for which the authors give their written permission by signing the corresponding Letter Of Agreement as a part of Author's Questionnaire, provided within the list of items to accompany the manuscript (questionnaire form is available on the site).

The above mentioned data is published for the convenience of the authors with the aim of the full and correct account of publications and their citation by the corresponding bibliography companies and providing the possibility of contacting the authors and the scientific community.

Personal information provided by the authors in addition to the referred above, include additional e-mails and phone numbers. These will be used exclusively for contacting the authors in the process of preparing the publication and will not be made available for any other purpose or to any other party.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies